From Medscape Nephrology

Kidney Week 2020: American Society of Nephrology Annual Meeting

October 22 - 25, 2020; Virtual

October 22 - 25, 2020 Virtual

KidneyWeek 2020 Benefits of SGLT2 Inhibitors Seen Across Patient Subgroups
Medscape Medical News, October 30, 2020
KidneyWeek 2020 Dapagliflozin Halves Hyperkalemia in Some HF Patients
Medscape Medical News, October 29, 2020
KidneyWeek 2020 Renal Allografts at Risk After ICIs for Subsequent Cancer
Medscape Medical News, October 28, 2020

KidneyWeek 2020 CV Benefit of Eicosapentaenoic Acid Seen at All eGFR Levels
Medscape Medical News, October 27, 2020
KidneyWeek 2020 Cardiovascular Safety Results for Anemia Drug Disappoint
Medscape Medical News, October 26, 2020
KidneyWeek 2020 Novel Drug Slows Progression of Diabetic Kidney Disease
Medscape Medical News, October 23, 2020

Discord Over Contrast-Induced Nephropathy Does contrast media cause acute kidney injury? Study results, which have been mixed, leave experts debating this question.
Medscape Medical News, Oct 31, 2019
Older Immunosuppressant as Good As Newer One, But 10 Times Cheaper Replacement of azathioprine with mycophenolate mofetil for kidney transplantation was a very costly move, with no discernible benefits in the era of modern immunosuppression, say authors of ATHENA.
Medscape Medical News, Nov 18, 2019
New Option for Difficult-to-Treat Uremic Pruritus A kappa opioid receptor agonist is safe and effective for the treatment of pruritus associated with chronic kidney disease, researchers report.
Medscape Medical News, Nov 11, 2019

Medscape Nephrology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Previous Coverage